Navigating the gluten-free minefield: keeping clients healthy on a GF diet isn't easy - why GF is a prerequisite in wheat-related disorders, but not the treatment

29 February 2020, Cavendish Conference Centre, London

75% of tickets now sold – book your place before it’s too late

Expert speaker

Course gluten-free lunch

Exhibitors

CPD hours/points

Navigating the gluten-free minefield: keeping clients healthy on a GF diet isn’t easy – why GF is a prerequisite in wheat-related disorders, but not the treatment.

 

A gluten-free diet (GFD) is often the cornerstone of many of our recommendations to our clients. We know its potential value and necessity, and how quickly people feel better on a GFD. But what is not commonly known is the association of a GFD with increased mortality. Tom is not only one of the world’s leading experts on what the latest research on wheat and gluten is telling us, but also there is no one better at explaining the down-to-earth clinical take-aways. He will explain just how easy it is it can be to guide our patients into balanced gluten-free diets that eliminate these increased unwanted health dangers, enhance health, reduce inflammation and improve quality of life.

A gluten-free diet (GFD) is often the corner pin of many of our recommendations to our Clients. We’ve all heard of its potential value and necessity. And how quickly people ‘feel better’ on a GFD. But what is not commonly known is the increase in mortality with a GFD. Although symptomatic relief is often obtained in a startling number of conditions, the long-term impact of GFDs can be devastating. There is an 86% increased risk of death from a cardiovascular incident in the first year after a client is diagnosed with celiac disease. And 3.78- fold increased risk of mortality from malignancy in the first year after celiac diagnosis. i. Further, comorbidities with wheat related disorders are high. Twentynine (29%) of those with non- celiac wheat sensitivity (NCWS) demonstrate elevated antinuclear antibodies. ii. Within 3 years, 87% of those who were originally aymptomtomatic with elevated ANA antibodies have been diagnosed
with an autoimmune disease. iii. Why is this happening and what can be done about it? Take-away? The Gluten-free Diet is the prerequisite in Wheat Related Disorders. It is not the treatment. We will address this unrecognized adverse reaction, it’s causes and mechanisms and treatment protocols guiding our clients who need to be gluten-free to a vibrant, healthy gluten-free lifestyle.

And with proper preparation, the good news is how easy it can be to guide our patients into balanced gluten-free diets that eliminate these increased unwanted health dangers, enhance health, reduce inflammation and improve quality of life iv.

Objectives:

• Developing a more comprehensive overview of wheat-related disorders
• Successfully and comprehensively identifying wheat-related disorders
• Understanding the causes of increased mortality after diagnosis
• Recognizing the frequency of detrimental impact on the epithelial
lining of the GI Tract with a wheat-related disorder
• Protocols successfully addressing the damage to the intestinal lining
• Recognizing the need for comprehensive dietary guidance for food selections (and avoidances)

References:

 

i Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F., Small-intestinal histopathology
and mortality risk in celiac disease. JAMA. 2009 Sep 16;302(11):1171-8
ii Carroccio A, Alcamo A, Cavataio F, Soresi M, Seidita A, Sciumè C, Geraci G, Iacono G,
Mansueto P., High Proportions of people with Nonceliac Wheat Sensitivity have Autoimmune
Disease or Antinuclear Antibodies, Gastroenterology. 2015 Sep;149(3):596-603
iii Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies. Pérez D,
Gilburd B, Cabrera-Marante Ó, Martínez-Flores JA, Serrano M, Naranjo L, Pleguezuelo D,
Morillas L, Shovman O, Paz-Artal E, Shoenfeld Y, Serrano A. Clin Chem Lab Med. 2017 Jun 17.
iv Barratt SM, Leeds JS, Sanders DS. Quality of life in coeliac disease is determined by perceived
degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately
achieved. J Gastrointestin Liver Dis. 2011 Sep;20(3):241-5

About Tom O'Bryan

Tom O’Bryan is a world expert on gluten and it’s impact on your health. He is an internationally recognised and sought after speaker and workshop leader specialising in the complications of Non-Coeliac Gluten Sensitivity, Coeliac Disease, and the development of Autoimmune Diseases as they occur inside and outside of the intestines. He is the founder of www.theDr.com and the visionary behind ‘The Gluten Summit – A Grain of Truth’, bringing together 29 of the world’s experts on the Gluten connection to diseases, disorders, and a wide-range of symptoms and ages. You can find this info at www.theglutensummit.com.

Tom O’Bryan is considered the ‘Sherlock Holmes’ for chronic disease and metabolic disorders. He is a clinician par excellence in treating chronic disease and metabolic disorders from a Functional Medicine Perspective. He holds adjunct Faculty positions with the Institute for Functional Medicine and the National University of Health Sciences. He has trained thousands of practitioners around the world in advanced understanding of the impact of food related disorders and the development of individual autoimmune diseases.

Tom O’Bryan

Exhibitors include:

  • Bio-Kult
  • Elenzia
  • Green People Company
  • Mycology Research Laboratories
  • Rio Health
  • Solgar UK
  • The Nutrition Coach
  • Zyto.

More to be confirmed in the coming weeks.

Book your place

Places are limited and often sell out, so guarantee your place before it’s too late.

Book your place before it's too late...

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Proudly supported by

       

Book your place